A Randomised Trial of Sequential Aromatase Inhibitors (AI) in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer. The SAINT Trial

http://isrctn.org/> ◽

10.1186/isrctn99515843 ◽

2012 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomised Trial ◽

Locally Advanced ◽

Metastatic Breast

Download Full-text

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

The Lancet Oncology ◽

10.1016/s1470-2045(13)70322-x ◽

2013 ◽

Vol 14 (10) ◽

pp. 989-998 ◽

Author(s):

Stephen RD Johnston ◽

Lucy S Kilburn ◽

Paul Ellis ◽

David Dodwell ◽

David Cameron ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Randomised Trial ◽

Locally Advanced ◽

Metastatic Breast ◽

Phase 3 ◽

Multicentre Phase ◽

Hormone Receptor Positive ◽

Steroidal Aromatase Inhibitors

Download Full-text

Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study

Clinical Breast Cancer ◽

10.1016/j.clbc.2019.01.015 ◽

2019 ◽

Vol 19 (3) ◽

pp. e452-e458

Author(s):

Yizhao Xie ◽

Yi Li ◽

Yinbin Zhang ◽

Shuqun Zhang ◽

Wei Li ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Retrospective Study ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Nonsteroidal Aromatase Inhibitors

Download Full-text

Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06173-z ◽

2021 ◽

Author(s):

Young-Hyuck Im ◽

Bulent Karabulut ◽

Keun Seok Lee ◽

Byeong-Woo Park ◽

Aditya Adhav ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Locally Advanced ◽

Metastatic Breast ◽

Safety And Efficacy

Download Full-text

Phase II, 3-arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer: preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.544 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 544-544 ◽

Author(s):

J. Baselga ◽

P. Fumoleau ◽

M. Gil ◽

R. Colomer ◽

H. Roche ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Locally Advanced ◽

Metastatic Breast ◽

Preliminary Results

Download Full-text

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.564 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 564-564 ◽

Author(s):

J. T. Carpenter ◽

H. Roché ◽

M. Campone ◽

R. Colomer ◽

A. Jagiello-Gruszfeld ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Locally Advanced ◽

Metastatic Breast ◽

Phase 2 ◽

Download Full-text

PCN132 ECONOMIC EVALUATION AND BUDGET IMPACT OF FULVESTRANT (FASLODEX®) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE NOT RECEIVED PRIOR ENDOCRINE THERAPY FROM THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM IN MEXICO

Value in Health ◽

10.1016/j.jval.2019.04.256 ◽

2019 ◽

Vol 22 ◽

pp. S81

Author(s):

F. Carlos ◽

J. Guzmán ◽

M. Naranjo ◽

M. Carmona

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Economic Evaluation ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Budget Impact ◽

Locally Advanced ◽

Metastatic Breast ◽

Public Healthcare ◽

Download Full-text

Phase II, 3-arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer: preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.544 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 544-544 ◽

Author(s):

J. Baselga ◽

P. Fumoleau ◽

M. Gil ◽

R. Colomer ◽

H. Roche ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Locally Advanced ◽

Metastatic Breast ◽

Preliminary Results

Download Full-text

Abstract OT2-3-08: Phase III randomized study of the oral pan-PI3K inhibitor BKM120 with fulvestrant in postmenopausal women with HR+/HER2– locally advanced or metastatic breast cancer, treated with aromatase inhibitor, and progressed on or after mTOR inhibitor-based treatment – BELLE-3

10.1158/0008-5472.sabcs12-ot2-3-08 ◽

2012 ◽

Author(s):

A Di Leo ◽

C Germa ◽

D Weber ◽

E Di Tomaso ◽

B Dharan ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Mtor Inhibitor ◽

Randomized Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Pi3k Inhibitor ◽

Download Full-text

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Annals of Oncology ◽

10.1093/annonc/mdw249 ◽

2016 ◽

Vol 27 (9) ◽

pp. 1719-1725 ◽

Author(s):

G. Jerusalem ◽

G. Mariani ◽

E.M. Ciruelos ◽

M. Martin ◽

V.C.G. Tjan-Heijnen ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Locally Advanced ◽

Metastatic Breast ◽

Multicenter Trial ◽

Hormone Receptor Positive ◽

Steroidal Aromatase Inhibitors

Download Full-text

1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04)

European Journal of Cancer ◽

10.1016/s0959-8049(16)30800-0 ◽

2015 ◽

Vol 51 ◽

pp. S282

Author(s):

P. Neven ◽

D. Generali ◽

E.M. Ciruelos ◽

I. Lang ◽

J.G. Gavila ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Aromatase Inhibitors ◽

Hormone Receptor ◽

Locally Advanced ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Steroidal Aromatase Inhibitors

Download Full-text